Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Find the latest Drugs in Development and Pipeline Prospector News of Curetis.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Curetis
Germany Flag
Country
Country
Germany
Address
Address
Max-Eyth-Str. 42 71088 Holzgerlingen
Telephone
Telephone
+49 (0)7031 / 49195-10
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

BV100 is a much-needed injectable formulation of rifabutin to treat serious infections caused by Carbapenem Resistant Acinetobacter baumannii in patients with ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia and bloodstream infections.


Lead Product(s): Rifabutin

Therapeutic Area: Infections and Infectious Diseases Product Name: BV100

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: BioVersys AG

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration October 25, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY